https://lutris-pharma.com/ weekly 1.0 https://lutris-pharma.com/technology monthly 0.9 https://lutris-pharma.com/technology/publications monthly 0.8 https://lutris-pharma.com/clinical-trials monthly 0.9 https://lutris-pharma.com/team monthly 0.7 https://lutris-pharma.com/team/board monthly 0.6 https://lutris-pharma.com/team/sab monthly 0.6 https://lutris-pharma.com/investor-relations weekly 0.7 https://lutris-pharma.com/patient-resources monthly 0.8 https://lutris-pharma.com/faq monthly 0.6 https://lutris-pharma.com/contact yearly 0.5 https://lutris-pharma.com/news/eadv-2026-positive-updated-data 2026-10-01 https://lutris-pharma.com/news/eadv-2026-updated-data 2026-09-16 https://lutris-pharma.com/news/esmo-gi-2025-additional-data 2025-07-03 https://lutris-pharma.com/news/esmo-gi-2025-to-present 2025-06-18 https://lutris-pharma.com/news/ceo-sumant-ramachandra 2025-04-29 https://lutris-pharma.com/news/aacr-2025-new-data 2025-04-28 https://lutris-pharma.com/news/aacr-2025-to-present 2025-03-26 https://lutris-pharma.com/news/30m-financing 2025-01-28 https://lutris-pharma.com/news/phase2-enrollment-complete 2024-10-15 https://lutris-pharma.com/news/mori-arkin-board 2024-04-01 https://lutris-pharma.com/news/fda-orphan-drug 2024-02-28 https://lutris-pharma.com/news/radiation-dermatitis-publication 2024-02-21 https://lutris-pharma.com/news/aad-2023 2023-03-17 https://lutris-pharma.com/news/ceo-forum-2023 2023-02-16 https://lutris-pharma.com/news/cirm-grant-lut017 2022-10-24 https://lutris-pharma.com/news/patent-mek-inhibitor 2022-09-14 https://lutris-pharma.com/news/phase12-top-line 2022-09-07 https://lutris-pharma.com/news/antoni-ribas-chairman 2022-05-10 https://lutris-pharma.com/news/bioequity-2022 2022-05-03 https://lutris-pharma.com/news/phase12-part-two-enrollment 2022-04-06 https://lutris-pharma.com/news/virtual-investor-2022 2022-01-04 https://lutris-pharma.com/news/ip-portfolio-2021 2021-12-08 https://lutris-pharma.com/news/phase12-part-two-initiates 2021-10-05 https://lutris-pharma.com/news/first-us-patients-phase2 2021-08-03 https://lutris-pharma.com/news/jack-weinstein-chairman 2021-06-29 https://lutris-pharma.com/news/cancer-discovery-publication 2021-04-28 https://lutris-pharma.com/news/news-medical-topical 2021-04-28 https://lutris-pharma.com/news/medscape-braf 2021-04-28